[go: up one dir, main page]

WO2006091180A3 - Fucoidan multiparticulate drug carrier systems - Google Patents

Fucoidan multiparticulate drug carrier systems Download PDF

Info

Publication number
WO2006091180A3
WO2006091180A3 PCT/TR2005/000015 TR2005000015W WO2006091180A3 WO 2006091180 A3 WO2006091180 A3 WO 2006091180A3 TR 2005000015 W TR2005000015 W TR 2005000015W WO 2006091180 A3 WO2006091180 A3 WO 2006091180A3
Authority
WO
WIPO (PCT)
Prior art keywords
fucoidan
drug carrier
carrier systems
multiparticulate drug
multiparticulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2005/000015
Other languages
French (fr)
Other versions
WO2006091180A2 (en
Inventor
Ali Demir Sezer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/TR2005/000015 priority Critical patent/WO2006091180A2/en
Publication of WO2006091180A2 publication Critical patent/WO2006091180A2/en
Publication of WO2006091180A3 publication Critical patent/WO2006091180A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

As a drug carrier system, the fucoidan multiparticulate systems are prepared with the interaction of fucoidan; a polysaccharide has an anionic character with chitosan also a polysaccharide and demonstrates cationic characteristics. In the preparation of these multiparticulate systems, neither organic solvents nor excipients are used as catalysts.
PCT/TR2005/000015 2005-02-25 2005-02-25 Fucoidan multiparticulate drug carrier systems Ceased WO2006091180A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/TR2005/000015 WO2006091180A2 (en) 2005-02-25 2005-02-25 Fucoidan multiparticulate drug carrier systems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2005/000015 WO2006091180A2 (en) 2005-02-25 2005-02-25 Fucoidan multiparticulate drug carrier systems

Publications (2)

Publication Number Publication Date
WO2006091180A2 WO2006091180A2 (en) 2006-08-31
WO2006091180A3 true WO2006091180A3 (en) 2007-03-15

Family

ID=36927853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2005/000015 Ceased WO2006091180A2 (en) 2005-02-25 2005-02-25 Fucoidan multiparticulate drug carrier systems

Country Status (1)

Country Link
WO (1) WO2006091180A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015161192A1 (en) * 2014-04-17 2015-10-22 Memorial Sloan Kettering Cancer Center Fucoidan nanogels and methods of their use and manufacture
WO2016056001A1 (en) 2014-10-06 2016-04-14 Algamed Therapeutics (A.M.T) Ltd Compositions comprising sulfated polysaccharides and uses thereof
CN106176666B (en) * 2016-07-14 2019-08-20 青岛明月海藻集团有限公司 A kind of anti-moisture absorption fucoidan product and preparation method thereof
US10736964B2 (en) 2017-05-01 2020-08-11 China Medical University Immunomagnetic nanocapsule and kit for treating cancer
WO2018201981A1 (en) * 2017-05-01 2018-11-08 中国医药大学 Immunomagnetic composition, preparation method and use thereof, and kit for treating cancer
CN110269842A (en) * 2019-07-03 2019-09-24 中国人民解放军陆军军医大学第二附属医院 A kind of natural nano grain preparation of anti-oxidation stress and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085917A2 (en) * 1982-02-09 1983-08-17 Amf Incorporated Fibrous media containing millimicron-sized particles
US4488969A (en) * 1982-02-09 1984-12-18 Amf Incorporated Fibrous media containing millimicron-sized particulates
WO1999018934A1 (en) * 1997-10-09 1999-04-22 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US6726934B1 (en) * 1997-10-09 2004-04-27 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US20040136961A1 (en) * 1997-10-09 2004-07-15 Ales Prokop Nanoparticulate composition for efficient gene transfer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085917A2 (en) * 1982-02-09 1983-08-17 Amf Incorporated Fibrous media containing millimicron-sized particles
US4488969A (en) * 1982-02-09 1984-12-18 Amf Incorporated Fibrous media containing millimicron-sized particulates
WO1999018934A1 (en) * 1997-10-09 1999-04-22 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US6726934B1 (en) * 1997-10-09 2004-04-27 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US20040136961A1 (en) * 1997-10-09 2004-07-15 Ales Prokop Nanoparticulate composition for efficient gene transfer

Also Published As

Publication number Publication date
WO2006091180A2 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
Wang Ansa-metallocene polymerization catalysts: Effects of the bridges on the catalytic activities
WO2006128692A3 (en) 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
AU2003236947A1 (en) Modified release, multiple unit drug delivery systems
WO2003011226A3 (en) Products and drug delivery vehicles
WO2004091446A3 (en) Medical device delivery systems
WO2010140007A3 (en) Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug
WO2008054676A3 (en) Medical devices and methods of using the same
WO2007086001A3 (en) Novel pyridine derivatives
WO2006097558A3 (en) Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules
WO2007144169A3 (en) Entacapone-derivatives
WO2006083958A3 (en) Systems and methods for use of structured and unstructured distributed data
AU2003214133A1 (en) Topical composition comprising a cyclofructan, a carrier and a drug
WO2005096744A3 (en) Oriented polymer fibers and methods for fabricating thereof
WO2007133944A3 (en) Topical administration of acyclovir
SI1831240T1 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2009051417A3 (en) Phenanthrene lactam derivatives having anticancer activity and method for the preparation thereof
WO2010005622A3 (en) Telescoping devices
WO2006091180A3 (en) Fucoidan multiparticulate drug carrier systems
WO2009026257A3 (en) Methods and compositions for controlling the bioavailability of poorly soluble drugs
WO2006097798A3 (en) System and method for services access for a node in hanover
WO2007143456A3 (en) Benzimidazol substituted thiophene derivatives with activity on plk
WO2006046114A3 (en) Osmotic dosage forms providing ascending drug release, and processes for their preparation
WO2007009989A3 (en) COMPOSITION CONTAINING A SIO2-NANOPARTICLE LIPOSOMAL DISPERSION AND AN ß-1,3-LINKED GLUCAN-ETHER DERIVATIVE
WO2006085228A3 (en) 9a-carbamoyl-y-aminopropyl and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 05736306

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 05736306

Country of ref document: EP

Kind code of ref document: A2